XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segments
6 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Business Segments Business Segments
Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses.

The tables below summarize information about our reportable segments.
 Three Months Ended September 30, 2023
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Total segment revenues*$244,423 $41,893 $286,316 
Cost of sales107,466 18,830 126,296 
Gross profit136,957 23,063 160,020 
Advertising and marketing35,389 4,713 40,102 
Contribution margin$101,568 $18,350 $119,918 
Other operating expenses 31,668 
Operating income $88,250 
* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.

 Six Months Ended September 30, 2023
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Total segment revenues*$490,566 $75,059 $565,625 
Cost of sales217,542 33,390 250,932 
Gross profit273,024 41,669 314,693 
Advertising and marketing66,790 9,543 76,333 
Contribution margin$206,234 $32,126 $238,360 
Other operating expenses 64,916 
Operating income $173,444 
* Intersegment revenues of $2.0 million were eliminated from the North American OTC Healthcare segment.


 Three Months Ended September 30, 2022
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Total segment revenues*$252,054 $37,219 $289,273 
Cost of sales113,533 14,731 128,264 
Gross profit 138,521 22,488 161,009 
Advertising and marketing39,316 4,503 43,819 
Contribution margin$99,205 $17,985 $117,190 
Other operating expenses 32,806 
Operating income $84,384 
* Intersegment revenues of $1.1 million were eliminated from the North American OTC Healthcare segment.
 Six Months Ended September 30, 2022
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Total segment revenues*$494,572 $71,760 $566,332 
Cost of sales216,454 28,750 245,204 
Gross profit 278,118 43,010 321,128 
Advertising and marketing74,728 9,042 83,770 
Contribution margin$203,390 $33,968 $237,358 
Other operating expenses 65,960 
Operating income $171,398 
* Intersegment revenues of $1.7 million were eliminated from the North American OTC Healthcare segment.


The tables below summarize information about our segment revenues from similar product groups.
Three Months Ended September 30, 2023
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Analgesics$29,976 $1,386 $31,362 
Cough & Cold25,970 7,263 33,233 
Women's Health55,000 7,072 62,072 
Gastrointestinal38,703 14,061 52,764 
Eye & Ear Care39,745 7,125 46,870 
Dermatologicals33,018 1,469 34,487 
Oral Care19,312 3,469 22,781 
Other OTC2,699 48 2,747 
Total segment revenues$244,423 $41,893 $286,316 

Six Months Ended September 30, 2023
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Analgesics$57,158 $2,228 $59,386 
Cough & Cold46,344 13,315 59,659 
Women's Health109,955 12,028 121,983 
Gastrointestinal83,384 26,971 110,355 
Eye & Ear Care79,216 11,146 90,362 
Dermatologicals67,696 2,807 70,503 
Oral Care41,038 6,491 47,529 
Other OTC5,775 73 5,848 
Total segment revenues$490,566 $75,059 $565,625 
Three Months Ended September 30, 2022
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Analgesics$32,750 $541 $33,291 
Cough & Cold24,058 7,168 31,226 
Women's Health59,379 4,745 64,124 
Gastrointestinal41,272 16,037 57,309 
Eye & Ear Care37,961 4,734 42,695 
Dermatologicals32,872 902 33,774 
Oral Care21,251 3,080 24,331 
Other OTC2,511 12 2,523 
Total segment revenues$252,054 $37,219 $289,273 
Six Months Ended September 30, 2022
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Analgesics$60,547 $994 $61,541 
Cough & Cold45,650 13,439 59,089 
Women's Health120,563 9,612 130,175 
Gastrointestinal81,339 30,064 111,403 
Eye & Ear Care76,572 9,470 86,042 
Dermatologicals62,327 1,908 64,235 
Oral Care42,226 6,250 48,476 
Other OTC5,348 23 5,371 
Total segment revenues$494,572 $71,760 $566,332